去纤苷2020价格
On October 22, 2013, it was approved for marketing by the European Union as the first treatment for severe hepatic veno-occlusive disease in adults and children undergoing hematopoietic stem cell transplantation.
On March 30, 2016, the U.S. Food and Drug Administration (FDA) approved defibrotide for the treatment of hepatic veno-occlusive disease (VOD) caused by hematopoietic stem cell transplantation in adults and children with renal and pulmonary dysfunction.
Defibrotide is the first and only drug to treat severe hepatic veno-occlusive disease. So what is the price of Defibrotide 2020?
The price of defibrotide: According to Medical Companion Travel, the price of defibrotide listed abroad is about 22,000. Due to the floating exchange rate, the price is different. Please consult Medical Companion Travel for the specific price!
How to administer defibrotide:
The recommended dose of defibrotide for adult and pediatric patients is 6.25 mg/kg given every 6 hours as a 2-hour intravenous infusion. The dose should be based on the patient's baseline weight, which is defined as the patient's weight before the HSCT preparation protocol.
Defibrotide was administered for a minimum of 21 days. If signs and symptoms of hepatic veno-occlusive disease do not resolve after 21 days, continue defibrotide until resolution of hepatic veno-occlusive disease or for a maximum of 60 days. Defibrotide must be diluted prior to infusion.
Prior to administration of defibrotide, confirm that the patient is not experiencing clinically significant bleeding and is hemodynamically stable on no more than one vasopressor. Defibrotide was administered by constant intravenous infusion over a 2-hour period.
Administer the diluted solution using an infusion set equipped with a 0.2 μm in-line filter. Flush the intravenous administration line (peripheral or central) with 5% Dextrose Injection, USP, or 0.9% Sodium Chloride Injection, USP, before and immediately after administration.
Recommended related hot articles: /newsDetail/74874.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)